Paris, France, January 27, 2021-The COVID-19 vaccine has begun to be distributed globally, and plenty of international locations are nonetheless struggling with a pointy enhance in infections. Owkin is a French-American startup firm and a pioneer in AI and federal studying in medical analysis. Although efficient vaccines have been out there, it has at all times targeted its COVID-19 analysis efforts on the pandemic that also requires public well being consideration.
In supporting the frontline well being system, they invested a number of sources to make investments a number of COVID-19-related hospitalization, which resulted in an AI severity score, Nature Communications this week. This machine studying mannequin is skilled on multimodal knowledge units, together with lung CT scans (a routine process on admission), is plug-and-play, and might predict the severity of the affected person’s illness prognosis, and its efficiency exceeds all different present bulletins Scoring benchmark. Using these scores can help hospital useful resource administration and planning, a function that’s generally ignored, and if correctly managed, can save lives. This analysis was achieved via a consortium referred to as ScanCovIA, which consists of Institut Gustave Roussy, Kremlin-Bicêtre APHP, Owkin, and the Digital Vision Center of Centrale Supélec and INRIA.
In addition, Owkin has additionally developed different machine studying fashions to uncover extra coronavirus epitopes which may be efficient in future vaccines. As the virus continues to mutate, we don’t but know the way lengthy the present vaccines will stay efficient, or, just like the flu, they may want to develop yearly or half a yr. In addition, it’s attainable to develop vaccines for genes which might be extra secure in viral DNA and fewer seemingly to mutate. Epitope prediction can pace up vaccine improvement by narrowing the vary of epitopes for testing within the laboratory, and might diversify our protection in opposition to future mutations of the virus. In addition, these fashions will be deployed exterior of vaccine analysis. They will also be utilized in oncology analysis. The final objective of machine studying for epitope discovery is to higher perceive the immune response-these traits of the mannequin have their place in numerous fields of precision medical analysis.
This French-American start-up firm makes a speciality of medical analysis on AI and joint studying. It is a multidisciplinary staff composed of 100 folks, with experience in analyzing real-world knowledge, and in depth expertise in utilizing superior machine studying strategies in multi-modal cohort analysis. Owkin was co-founded in 2016 by Dr. Thomas Cloclozel, a scientific analysis physician, former assistant professor of scientific hematology, and Dr. Gilles Wainrib, a pioneer within the area of organic synthetic intelligence, and not too long ago printed a groundbreaking paper on synthetic intelligence and medical cutting-edge analysis Nature Medicine, Nature Communications with Hepatology.
The Owkin platform connects the most important medical analysis facilities and pharmaceutical firms in Europe and the United States within the joint analysis ecosystem. Owkin can get hold of medical insights from remoted knowledge units to assist life science firms uncover new medicine, determine novel biomarkers, optimize scientific trials and speed up affected person analysis.
To study extra, please go to http: // www.
Disclaimer: AAAS and EurekAlert! No accountability is assumed for the accuracy of press releases posted to EurekAlert! Use any data via donor companies or via the EurekAlert system.